Corporate Documents

OKYO Pharma Corporation (formerly West African Minerals Corporation) was incorporated and registered in the British Virgin Islands on 4 July 2007 for the purpose of making investments and/or acquisitions following a general meeting of shareholders on 10 January 2018, the Company adopted a strategy of seeking acquisition opportunities in the life sciences and biotechnology sector.

The Company’s head office is located in the British Virgin Islands. Currently the Company’s main country of operation and trading address is the United Kingdom.

OKYO Pharma Corporation is a British Virgin Islands incorporated company and as such shareholders' rights may be different from those of a UK incorporated company.

Memorandum of Association
Articles of Association
9 December 2011
Click here to download (PDF 1.58 MB)


Proposed Disposal and Special Dividend, Change of Name and Notice of General Meeting

21 December 2017

Click here to download (PDF 502 KB)


General Meeting Voting
10 January 2018
Click here to download (PDF 30 KB)


Cancellation of AIM Listing and Migration Circular
21 February 2018
Click here to download (PDF 249 KB)